|
4/16/2013 3:35:30 AM
|
|
|
4/16/2013 1:18:33 AM
|
|
|
4/16/2013 1:04:46 AM
|
Actelion Q1 Core Earnings CHF 168.5 Mln, Up 44% In Local Currencies
|
|
3/14/2013 2:05:21 AM
|
Actelion Nominates John Greisch For Election To Board Of Directors
|
|
2/14/2013 2:13:41 AM
|
|
|
2/14/2013 1:03:35 AM
|
Actelion Posts FY Core Earnings (excluding DDP) Of CHF 537.0 Mln
|
|
12/14/2012 2:14:45 AM
|
|
|
12/14/2012 1:43:34 AM
|
Actelion Says FDA Accepts NDA For Macitentan
|
|
10/22/2012 1:19:39 AM
|
|
|
10/22/2012 1:04:58 AM
|
Actelion Submits NDA To FDA For Macitentan
|
|
10/18/2012 1:22:51 AM
|
|
|
10/18/2012 1:05:13 AM
|
Actelion Posts 9-month Total Product Sales Of CHF 1.3 Bln
|
|
9/11/2012 2:33:52 AM
|
|
|
9/11/2012 1:23:47 AM
|
|
|
9/11/2012 1:05:31 AM
|
Actelion Implements Cost Saving Initiative; Confirms 2012 Earnings Guidance
|
|
9/10/2012 1:07:15 AM
|
Actelion To Present Macitentan Phase III PAH Outcome Study Results At CHEST 2012
|
|
7/19/2012 3:06:44 AM
|
|
|
7/19/2012 1:16:42 AM
|
|
|
7/19/2012 1:04:38 AM
|
Actelion Posts Half Year Total Product Sales Of CHF 861.8 Mln
|
|
7/12/2012 1:42:33 AM
|
|